72
Views
45
CrossRef citations to date
0
Altmetric
Review

Natural products and synthetic compounds as immunomodulators

, &
Pages 319-335 | Published online: 10 Jan 2014

References

  • Abel G, Szollosi J, Chihara G, Fachet J. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. int. I Immunophatmacol 11(6), 615–621 (1989).
  • Aggarwal P, Handa R, Singh S, Wali JR Kala-Azar — new developments in diagnosis and treatment. Indianj Pecliatr. 66,63–71.
  • Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science280, 1432–1435 (1998).
  • Amiel C, Darcissac E, Truong MJ, et al. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects and serum IL-16 levels drop with disease progression. J. Infect. Dis. 179,83–91 (1999).
  • •Excellent example for the potential of recombinant IL-16 in regulating HIV-1 replication and the use of IL-16 serum levels to monitor progression of disease.
  • Araujo EG, Persechini PM, Oliveira-Castro GM. Electrophysiology of phagocytic membranes. Role of divalent cations in membrane hyperpolarizations of macrophage polykaryons. Biochim. Biophys. Acta. 856(2), 362–372 (1986).
  • Arulanandam BP, Mittler JN, Lee WT, et al. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines. I Immunol 164(7), 3698–3704 (2000).
  • Azuma I, Seya T Development of Immunoadjuvants for immunotherapy of cancer. Int. J. Immunopharmacol 1, 1249–1259 (2001).
  • Bailer RT, Holloway A, Sun J, et al. IL-13 and IFN-gamma secretion by activated T-cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J. Immunol 162,7534–7542 (1999).
  • Bailer RT, Lee B, Montaner U. IL-13 and TNF-a inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur. j Immunol 30(5), 1340–1349 (2000).
  • Bancroft AJ, Artis D, Donaldson DD, Sypek JP, Grencis RK. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur j Immunol 30(7), 2083–2091 (2000).
  • Bancroft AJ, McKenzie ANJ, Grencis R.K. A critical role for IL-13 in resistance to intestinal nematode infection. J. immund 160,3453–3461 (1998).
  • Bauer R, Hoheisel O, Stuhlfauth I, Wolf H. Extract of the Echinacea purpurea herb: an allopathic phytoimmunostimulant. Wien Med. Wochenschr 149(8–10), 185–189 (1999).
  • •This article provides interested readers a concise introduction to the pharmacology of Echinacea products and lists related references for advanced studies.
  • Bauer R. Echinacea drugs — effects and active ingredients. Z 1.4rztl. Fortbild. (Jena) 90(2), 111–115 (1996).
  • Bauer R, Jurcic K, Puhlmann J, Wagner H. Immunologic in vivo and in vitrostudies on Echinacea extracts. Arzneimittelforschung 38(2), 276–281 (1988).
  • Baumhofer JM, Beinhauer BG, Wang JE, et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. Immunol 28,610–615 (1998).
  • Benyouce S, Hober D, Groote DD, et al. A decreased production of IL12 in vitro is associated with isolation of cytopathic HIV-1 strains in HIV-1-infected patients. J. Med. Viral. 55,209–214 (1998).
  • Bliss SK, Butcher BA, Denkers EY. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol 165 (8), 4515–4521 (2000).
  • Bohle A, Doehn C, Kausch I, Jocham D. Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-Guérin. j Ural 160,394–396 (1998).
  • Bohn E, Sing A, Zumbihl R, et al. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in and promotes resolution of, bacterial infection in mice. J. Immunol 160, 299–307 (1998).
  • Bolchin B, Haidvogl M, Heger M. Umckaloabo im. Vergleich mit Acetylcystein bei Kindern mit akuter Bronchitis. Der Kassenatzt 49, 46–49 (1999).
  • Bolton T, Casley-Smith JR. An in vitro demonstration of proteolysis by macrophages and its increase with coumarin. Experientia 31(3), 271–273 (1975).
  • Bukreyev A, Whitehead SS, Bukreyeva N, Murphy BR, Collins PL. Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc. Natl Acad. Sci. USA 96,2367–2372 (1999).
  • Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG. Echinacea-induced cytokine production by human macrophages. Int. J. Immunopharmacol 19(7), 371–379 (1997).
  • Carr JA, Rogerson JA, Mulqueen MJ, Roberts NA, Nash AA. The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40.1 Interferon Cytokine Res. 19, 1145–1152 (1999).
  • Chae SH, Kim PS, Cho YS, et al. Isolation and identification of inhibitory compounds on TNF-a production from Magnolia fargesii. Arch. Pharm. Res. 21(1), 67–69 (1998).
  • Chan OT, Yang LX. The immunological effects of taxanes. Cancer Immunol Immunother 49(4–5), 181–185 (2000).
  • Cho JY, Kim AR, Yoo ES, et al. Immunomodulatory effect of arctigenin, a lignan compound, on tumor necrosis factor-CL and nitric oxide production and lymphocyte proliferation. J. Pharm. Pharmacol 51(11), 1267–1273 (1999).
  • Cho JY, Park J, Yoo ES, et al. Inhibitory effect of lignans from the rhizomes of Coptis japonica vat: dissecta on tumor necrosis factor-a production in lipopolysaccharide-stimulated RAW 264.7 cells. Atch. Pharm. Res. 21(1), 12–16 (1998).
  • Choi BK, Cho SH, Bai GH, et al. Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes 49(9), 1459–1467 (2000).
  • Corral RS, Petray PB. CpG DNA as a Thl-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19(2–3) 234–242 (2000).
  • de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Sa/monelia infections in interleukin-12 receptor-deficient patients. Science 280,1435–1438 (1998).
  • De Pauw BE. New antifungal agents and preparations. Int. J. Antimiavb. Agents 16(2), 147–150 (2000).
  • Dellinger EP, Babineau TJ, Bleicher R, et al Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Atch. Sing 134,977–983 (1999).
  • Djeraba A, Quere P. 117 vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera. Int. Immunopharmacol 22 (5), 365–372 (2000).
  • Dome L, Schuster R. Umckaloabo — eine phytotherapeutische Alternative bei akuter Bronchitis im. Kindesalter. Arztez. Naturheilverfahren 3,216–222 (1996).
  • Dubreuil-Lemaire ML, Gori A, Vittecoq D, et al. Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomized, placebo-controlled trial in AIDS patients. Eur. j 1-Lematol. 65, 337–343 (2000).
  • Dybing JK, Walters N, Pascual DW. Role of endogenous interleukin-18 in resolving wild type and attenuated Salmonella Ophimurium infections. Infect. Immun. 67, 6242–6248 (1999).
  • Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. j Immund 162,2291–2298 (1999).
  • Falk, LA, Goldenthal, KL, Esparza J, et al. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV Type 1 vaccines. AIDS Res. Hum. Retroviruses 16(2), 91–98 (2000).
  • Fehniger TA. interleukin-15: biology and relevance to human disease. Blood 97(1), 14–32 (2001).
  • Feng ZH, Zhang GM, Hao TL, Zhou B, Zhang H, Jiang ZY. Effect of diallyl trisulfide on the activation of T-cell and macrophage-mediated cytotoxicity. I Tongji Med. Univ 14(3), 142–147 (1994).
  • Finkelman FD, Wynn TA, Donaldson DD, Urban JE The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Cud: Opin. Immuno1.11, 420–426 (1999).
  • Franz H. Mistletoe lectins and their A and B chains. Oncology43(Suppl. 1(2), 23–34 (1986).
  • Geng Y, Berencsi K, Gyulai Z, Valyi-Nagy T, Gonczol E, Trinchieri G. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumordae infection. Infect. Immun. 68(4), 2245–2253 (2000).
  • Gilson RJ, Shupack JL, Friedman-Kien AE, et al. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group. AIDS 13,2397–2404 (1999).
  • Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a Phase VII trial. j Med. 29, 305–330 (1998).
  • Grattendick K, Jansen DB, Lefkowitz DL, Lefkowitz SS. Cocaine causes increased Type I interferon secretion by both L929 cells and murine macrophages. Clin. Diagn. Lab. Immunol. 7(2), 245–250 (2000)
  • Grevers G, Palacios OA, Rodriguez B, Abel S, van Aubel A. Treatment of recurrent respiratory tract infections with a polyvalent bacterial lysate: results of an open, prospective, multinational study. Adv. Ther. 17(2), 103–116 (2000).
  • Hadden JW, Ongradi J, Specter S, et al. Methyl inosine monophasphate: a potential immunotherapeutic for early human immunodeficiency virus (HIV) infection. Int. J. Immunopharmacol. 14,555–563 (1992)
  • Hadden JW, Giner-Sorolla A, Hadden EM. Methyl inosine monophosphate (MIMP), a new purine immunomodulator for HIV infection. Int. j Immunopharmacol 13, 49–54 (1991).
  • Hajto T, Hostanska K, Gabius HJ. Zytokine als lectininduzierte Mediatoren in der Misteltherapie. Therapeutikon 4, 136–145 (1990).
  • Hajto T, Hostanka K, Gabius HJ. Modulatory potency of the 13-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. 49, 4803–4808 (1989).
  • Han SB, Kim YH, Lee CW, et al. Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai. Immunopharmacol 40(1), 39–48 (1998).
  • Haraguchi S, Day NK, Nelson RPJ, et al. interleukin-12 deficiency associated with recurrent infections. Proc. Nati Acad. Li. USA 95,13125–13129 (1998).
  • ••An important report on IL-12 deficiencyand recurrent episodes of infection in human patients.
  • Hardt TJ, Ritschel WA, The effect of coumarin and 7-hydroxycoumarin on in vitro macrophage phagocytosis of latex particles. Methods Find. Exp. Clin. Pharmacol 5(1), 39–43 (1983).
  • Hengel H, Masihi, KN. Combinatorial immunotherapies for infectious diseases. Int. Immunopharmacol. 3,1–9 (2003).
  • •Reviews recent approaches to combination chemotherapies and imrnunomodulators.
  • Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immund 116, 276–282 (1999).
  • Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Phatmacol. 27(4), 713–22 (1996).
  • Hu ZL, Thang JP, Hi YH, Qian DH. Effect of esculentoside H on release of tumor necrosis factor from mouse peritoneal macrophages. Zhongguo Yao Li Xue Bao 14(6), 550–552 (1993).
  • Huang J, Wang, MD, Lenz S, Gao D, Kaltenboeck B. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. Immunol 162,2217–2226 (1999).
  • Hwang S, Ding A. Activation of NF-kappa B in murine macrophages by taxol. Cancer Biochem. Biophys. 14(4), 265–272 (1995).
  • Ireland DD, Bang T, Komatsu T, Reiss CS. Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis. Vitalimmund 12, 35–40 (1999).
  • Ishikawa K, Tanaka H, Matsuoka T, Shimazu T, Yoshioka T, Sugimoto H. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.j Trauma. 44,1047–1054 (1998).
  • Jacobson MA, Spritzler J, Landay A, et al. Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS16, 1147–1154 (2002).
  • Joris F, Girard JR Immune response in aged and young subjects, following administration of large doses of tuberculin. Int. Arch. Allergy Appl. Immunol 48(5), 584–596 (1975).
  • Jouanguy E, Doffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Cum Opin. Immunol 11,346–351 (1999).
  • Kaiser AB, Kernodle DS. Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea-pig model. Antimicrob. Agents Chemother. 42, 2449–2451 (1998).
  • Kang TH, Pae HO, Jeong SJ, et al. Scopoletin: an inducible nitric oxide synthesis inhibitory active constituent from Artemisia feddei. Planta Med. 65 (5), 400–403 (1999).
  • Kayser O, Kolodziej H. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium mniforme. Ranta Med. 63(6), 508–510 (1997).
  • Kayser O. Phenolische Inhaltsstoffe von Pelargonium sidoides DC. und Untersuchungen zur Wirksamkeit der Umcka-Droge (P sidoides DC. und reniforme CURT). Shaker Verlag, Aachen (1997)
  • Kayser O, Kolodziej H, Kiderlen AF Immunomodulatory principles of Pelargonium sidoides. Phytother. Res. 15, 122–126 (2001).
  • Kemper, CA, Bermudez, LE, Deresinski SC. Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. j Infect. Dis. 177,914–920 (1998).
  • Khawaja TA, Dias CB, Pentecost S. Recent studies on the anticancer activities of mistletoe ( Viscum album) and its alkaloids. Oncology43(Suppl. 1), 42–50 (1986).
  • Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol 58(5), 759–765 (1999).
  • Kim KH, Lee YS, Jung IS, et al. Acidic polysaccharide from Panax ginseng ginsan, induces Thl cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Ranta Med. 64(2), 110–115 (1998)
  • Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect. Immun. 67,5658–5663 (1999).
  • Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus Type 1 in thermally injured mice. Iminunol 162,7148–7154 (1999).
  • Koliouskas D, Sidiropoulos I, Masmanidou M, Dokas S, Ziakas A. Comparative analysis of Peg-interferon a-2b and lamivudine in the treatment of chronic hepatitis B patients: preliminary results. Hepatology36, 237–238 (2002).
  • Kolodziej H, Kayser O, Radtke OA, Kiderlen AF Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomed 10 (Suppl. 18–24 (2003).
  • Kolodziej H, Kayser O, Latté IQ, Kiderlen AF. Enhancement of antimicrobial activity of tannins and related compounds by immune modulatory effects. Basic Life Sci 66(4), 575–594 (1999).
  • Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon31(12), 1513–1540 (1993).
  • Kosaka T, Kaneko Y, Nakada Y, Matsuura M, Tanaka S. Effect of chitosan implantation on activation of canine macrophages and polymorphonuclear cells after surgical stress.J Vet. Med. ScL 58(10), 963–967 (1996).
  • Kremer L, Dupre L, Wolowczuk I, Locht, C. In viva immunomodulation following intradermal injection with DNA encoding IL-18.1 Immund 163,3226–3231 (1999).
  • Kreofsky T, Schlager JW, Vuk-Pavlovic, Abraham RT, Rohrbach MS. Condensed tannin promotes the release of arachidonic acid from rabbit resident alveolar macrophages. Am. j Respir. Cell Mal Biol. 7(2), 172–181 (1992).
  • Kreofsky TJ, Russell JA, Rohrbach MS. Inhibition of alveolar macrophage spreading and phagocytosis by cotton bract tannin. A potential mechanism in the pathogenesis of byssinosis. Am j Pathol 137(2), 263–274 (1990).
  • Krieg AM. CpG motifs in bacterial DNA and their immune effects. Ann. Rev Iminunol. 20,709–760 (2002)
  • Krieg AM, Love-Homan L, Yi AK, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. immund 161, 2428–2434 (1998).
  • Kumazawa Y, Takimoto, H, Nishimura C, Kawakita T, Nomoto K. Activation of murine peritoneal macrophages by saikosaponin a, saikosaponin d and saikogenin d. Int. j Immunopharmacol 11(1), 21–28 (1989).
  • Kuritzkes DR. Clinical experience with Filgrastim in AIDS. I Hematother. Stem. Cell Res. 8, S17—S19 (1999).
  • Ladanyi A, Timar J, Lapis K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Iminunother. 36(2), 123–126 (1993).
  • Landau A, Batisse D, Van Huyen JP, et al. Efficacy and safety of combination therapy with interferon-a2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS14 (7), 839–844 (2000).
  • Lau BH, Yamasaki T, Gridley DS. Garlic compounds modulate macrophage and T-lymphocyte functions. Mal Blather. 3(2), 103–107 (1991).
  • Lawson CM, Beilharz MW. Low-dose oral use of interferon inhibits virally induced myocarditis.j Interferon Cytokine Res. 19, 863–867 (1999).
  • Lemaire, I, Assinewe V, Cano P, Awang DV, Arnason JT. Stimulation of interleukin-1 and-6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (una de gato). I Ethnopharmacol 64(2), 109–115 (1999).
  • Leung KN, Yeung HW, Leung SO. The immunomodulatory and antitumor activities of trichosanthin — an abortifacient protein isolated from tian-hua-fen ( Richosanthes kirilowb). Asian Pac. Allergy Immunol 4 (2), 111–120 (1986).
  • Lin SJ, Yang MET, Chao HC, Kuo ML, Huang JL. Effect of interleukin-15 and F1t3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol 11(3), 168–174 (2000).
  • Liu M, Li J, Kong F, Lin J, Gao Y. Induction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodes. Immunopharmacol 40(3), 187–198 (1998).
  • Lu H, Yang X, Takeda K, etal. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity. Mal Med. 6(7) 604–612 (2000).
  • Luettig B, Steinmilller C, Gifford GE, Wagner H, Lohmann-Matthes ML. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. j Natl Cancer Inst. 81 (9), 669–675 (1989).
  • Luo YM, Cheng XJ, Yuan WX. Effects of ginseng root saponins and ginsenoside Rbl on immunity in cold water swim stress mice and rats. Zhongguo Yao Li Xue Bao 14(5), 401–404 (1993).
  • Luo ZW, Fan XJ, Zhou NM, et al. Structure-function study and antiHIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II. Biochemistry39, 13545–13550 (2000).
  • Luty AJ, Perkins DJ, Le11 B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68(7), 3909–3915 (2000).
  • Marshall ME, Conley D, Hollingsworth, P, Brown S, Thompson JS. Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell and monocyte functions in vitro. Response Mod 8(1), 70–85 (1989).
  • Masihi KN. Concepts of immunostimulation to increase antiparasitic drug action. Patositol Res. (2003).
  • Masihi KN, Hadden JW. Protection by methyl inosine monophosphate (MIMP) against aerosol influenza virus infection in mice. Int. Immunopharmacol 2,835–841 (2002).
  • Masihi KN. Fighting infection using Immunomodulatory agents. Expert. Opin. Ther 1,641–653 (2001).
  • Masihi KN. Immunomodulatory agents for prophylaxis and therapy of infections. int. Antimiavb. Agents 14,181–191 (2000).
  • •This paper presents the chemical structure of many important imrnunomodulators.
  • Masihi KN (Ed.) Immunotherapy of Infections. Marcel Dekker, Hong Kong, 1–508 (1994).
  • Mastroianni CM, d'Ettorre G, Forcina G, et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. B/ooc/ 96(5), 1979–1984 (2000).
  • Matsukawa A, Hogaboam CM, Lukacs NW, et al. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. I immunol 164(5), 2738–2744 (2000).
  • Matthiessen PF, Tröger W Die Misteltherapie des Krebses. In: Kombinierte Tumortherapie (2nd Edition). Wrba H (Ed.). Hippokrates Verlag, Stuttgart, Germany, 271–290 (1995)
  • May WS, Sharkis SJ, Esa AH, et al. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proc. Natl Acad. Li. USA 84(23), 8483–8487 (1987).
  • McKenzie GJ, Bancroft A, Grencis RIK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. 0.117: Bia 8,339-342 (1998).
  • Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA. Imiquimod applied topically: a novel immune response modifier and new class of drug. int. Immunopharmacol 21,1–14 (1999).
  • Miyamoto K, Nomura M, Sasakura M, et al. Antitumor activity and interleukin-1 induction by tannins. Anticancer Res. 13(1), 37–42 (1993).
  • Mohan K, Sam H, Stevenson MM. Therapy with a combination of low doses of interleukin-12 and chloroquine completely cures blood-stage malaria, prevents severe anemia and induces immunity to reinfection. Infect. IMMUIL 67, 513–519 (1999).
  • Mombelli B, Gismondo M. The use of probiotics in medical practice. int. Antimicrob. Agents 16,531–536 (2000).
  • Montaner LJ, Bailer RT, Gordon S. IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production and reduce virus infectivity. j Leukoc. Biol. 62,126–132 (1997).
  • Mullins DW, Alleva DG, Burger CJ, Elgert KD. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacol 37(1), 63–73 (1997).
  • Mullins DW, Burger CJ, Elgert KD. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide." Immunol 162(11), 6811–6818 (1999).
  • Murakami A, Gao G, Kim OK, et al. Identification of coumarins from the fruit of Citrus hystrixDC as inhibitors of nitric oxide generation in mouse macrophage RAW 264.7 cells. Agric. Food Chem. 47(1), 333–339 (1999).
  • Nagy-Agren SE, Cooney EL. Interleukin-12 enhancement of antigen-specific lymphocyte proliferation correlates with stage of human immunodeficiency virus infection. j Infect. Dis. 179,493–496 (1999).
  • Nascimento IP, Dias WO, Mazzantini RP, et al. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit 51 induces protection against an intracerebral challenge with live RonJeteilapertussisin mice. Infect. Immun. 68(9), 4877–4883 (2000).
  • Nielsen SD, Sorensen TU, Aladdin H, et al. The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals. Scand. Immunol 52(3), 298–303 (2000).
  • Ogura K, Ohta S, Ohmori T, et al. Vinca alkaloids induce granulocyte-macrophage colony stimulating factor in human peripheral blood mononuclear cells. Anticancer Res. 20(4), 2383–2388 (2000).
  • Osebold JW. Mechanisms of action by immunologic adjuvants. j Am. Vet. Med. Assoc. 181(10), 983–987 (1982).
  • Oxenius A, Martinic MM, Hengartner H, Klenerman P CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. 'Viral 73,4120–4126 (1999).
  • Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT. Inhibition of Chlamydia pneumordae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity. Infect. Immun. 68, 6478–6481 (2000).
  • Park YC, Rimbach G, Saliou C, Valacchi G, Packer L. Activity of monomeric, dimeric and trimeric flavonoids on NO production, TNF-a secretion and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett. 465(2–3), 93–97 (2000).
  • Pimstone NR, Canio JB, Chiang MH. Ribavirin/interferon-2b therapy is very effective in the treatment of chronic hepatitis C genotype 2 and 3 patients who have failed to respond virologically to IFN monotherapy. Gastroenterology120, A382 (2001).
  • Pinto LA, Williams MS, Dolan MJ, Henkart PA, Shearer GM. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. Eur.J. Immunol 30 (7), 2048–2055 (2000).
  • Pitrak DL. Filgrastim treatment of HIV-infected patients improves neutrophil function. AIDS13(Suppl. 2), S25—S30 (1999).
  • Plohmann B, Bader G, Hiller K, Franz G. Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie 52(12), 953–957 (1997).
  • Polo S, Nardese V, De Santis C, et al. Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation. Eur I Immunol 30, 3190–3198 (2000).
  • Qiu Z, Jones K, Wylie M, Jia Q, Orndorff S. Modified Aloe barbadensispolysaccharide with immunoregulatory activity. Planta Med. 66(2), 152–156 (2000).
  • Rabinovich GA, Rubinstein N, Toscano MA. Role of galectins in inflammatory and immunomodulatory processes. Biochim. Biophys. Acta 1572,274–284 (2002).
  • Raeder RII, Barker-Merrill L, Lester T, Boyle MD, Metzger DW. A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. j Infect. Dis. 181 (2), 639–645 (2000).
  • Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. j Leukocyte Biol. 68(4), 503–510 (2000).
  • Rodriguez-Adrian LJ, Grazziutti ML, Rex JH, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed? Clin. Infect. Dis. 26,1270–1278 (1998).
  • Roesler J, Steinmaller, C, Kiderlen AF, Emmendorffer A, Wagner H, Lohmann-Matthes ML. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int.. 1. Imutunopharmacol 13(1), 27–37 (1991).
  • Rohrbach MS, Kreofsky TJ, Vuk-Pavlovic Z, Lauque D. Cotton condensed tannin: a potent modulator of alveolar macrophage host-defense function. Basic Life Sci 59(2), 803–824 (1992).
  • Rohrbach MS, Kreoksk T, Rolstad RA, Russell JA. Tannin-mediated secretion of a neutrophil chemotactic factor from alveolar macrophages. Potential contribution to the acute pulmonary inflammatory reaction associated with byssinosis. Am. Rev. Respir. Dis. 139 (1), 39–45 (1989).
  • Rohrbach MS. Modulation of alveolar macrophage function by condensed tannin. Am. Ind Med. 25(1), 97–99 (1994).
  • Rusconi S, La Seta C, Citterio P Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus Type 1 infection: in vitro studies of mixed virus infections. J. Vim!. 74(19), 9328–9332 (2000)
  • Sai Ram M, Sharma SK, Ilavazhagan G, Kumar D, Selvamurthy W Immunomodulatory effects of NIM-76, a volatile fraction from Neem oil. Ethnopharmacol 55(2), 133–139 (1997).
  • Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. Am. Acad. Dermatol 43(1.Pt.2.), S6—S11 (2000).
  • Seo W, Pae HO, Kim NY, et al. Synergistic co-operation between water-soluble chitosan oligomers and interferon-gamma for induction of nitric oxide synthesis and tumoricidal activity in murine peritoneal macrophages. Cancer Lett. 159 (2), 189–195 (2000).
  • Shin KS, Kiyohara H, Matsumoto T, Yamada H. Rhamnogalacturonan II from the leaves of Panax ginseng- C.A. Meyer as a macrophage Pc receptor expression-enhancing polysaccharide. Carbohydrate Res. 300(3), 239–249 (1997).
  • Silva RA, Pais TF, Appelberg R. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. j Immunol 161, 5578–5585 (1998).
  • Sin JI, Kim JJ, Pachuk C, Satishchandran C, Weiner DB. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Thl-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus Type 2 in vivo. j Vim'. 74(23), 11173–11180 (2000).
  • Slade HB. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod. Eur. Dermatol 8,13–16 (1998).
  • Sosa M, Noso, Y, Hadden JW. Methyl inosine monophosphate (MIMP) stimulates macrophage related functions in vitro and in vivo. Int.. 1. Imutunopharmacol 13,762 (1991).
  • Stacey KJ, Blackwell JM. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania moja: Infect. Immun. 67,3719–3726 (1999).
  • Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin. Exp. Dermatol 27,571–577 (2002).
  • Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel, SL. Multiple roles for IL-12 in a model of acute septic peritonitis. j Immunol 162,5437–5443 (1999).
  • Steinhauser ML, Hogaboam CM, Matsukawa A, Lukacs NW, Strieter RIVI, Kunkel SL. Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis. Infect. Immun. 68,6108–6114 (2000).
  • Steinmaller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes ML. Polysaccharides isolated from plant cell cultures of Echinaceapurpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int.. 1. Imutunopharmacol 15(5), 605–614 (1993).
  • Stimpel M, Proksch A, Wagner H, Lohmann-Matthes ML. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpuma. Infect. Immun. 46(3), 845–849 (1984).
  • Stokes JR, Sorkness RL, Kaplan MR, et al. Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur. Respir.j 11,324–329 (1998).
  • Suzuki M, Arika T, Amemiya K, Fujiwara M. Co-operative role of T-lymphocytes and macrophages in antitumor activity of mice pretreated with schizophyllan (SPG). Jpn Exp. Med. 52(2), 59–65 (1982).
  • Syed TA, Ahmadpour OA, Ahmad SA, Ahmad SH. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. I Dermatol 25, 429–433 (1998).
  • Tielemans C, Gastaldello K, Husson C, et al. Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study. Clin. Nephrol 51,153–160 (1999).
  • Tokura S, Tamura H, Azuma I. Immunological aspects of chitin and chitin derivatives administered to animals. Experient87 (2), 279–292 (1999).
  • Tompkins WA. Immunomodulation and therapeutic effects of the oral use of interferon-a: mechanism of action. Interferon Cytokine Res. 19,817–828 (1999).
  • Touraine JL, Sanhadji K, de Bouteillier O, Hadden JW. In vitm effects of inosine monophosphate methyl (Me-IMP) on human prothymocyte differentiation. int.,/ Immunophatmacol 13,761 (1991).
  • Trofatter KFJ. Imiqimod in clinical practice. Eur. j Dermatol 8,17–19 (1998).
  • Truong MJ, Darcissac EC, Hermann E, Dewulf J, Capron A, Bahr GM. Interleukin-16 inhibits human immunodeficiency virus Type 1 entry and replication in macrophages and in dendritic cells. j Viral 73,7008–7013 (1999).
  • Tsunobuchi H, Nishimura H, Goshima F, et al. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology275(1), 57–66 (2000).
  • Tzianabos AO, Gibson PC, Cisneros RL, Kasper DL. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators. Infect. Dir. 178,200–206 (1998).
  • USW S, Tomono Y, Sakai M, Kiho T, Ukai S. Preparation and antitumor activities of beta-(16) branched (1 3)-beta-D-glucan derivatives. Biol. Pharm. Bull. 18(12), 1630–1636 (1995).
  • van Schaik SM, Obot N, Enhorning G, et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med. ViroL 62,257–266 (2000).
  • van Wely Stoss M, Gorter RVV. Toxicity of standardized mistletoe extract in immunocompromised and healthy individuals. Am.j Ther. 6,100–105 (1999).
  • Vazquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candicla albicans. Infect. Immun. 66,145–150 (1998).
  • Vicenzi E, Alfano M, Ghezzi S, et al. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-la and MCP-3 and enhancement by MCP-1. j Leukoc.68(3), 405-412(2000).
  • Visioli F, Bellosta S, Galli C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 62(6), 541–546 (1998).
  • Vomel T Effect of a plant immunostimulant on phagocytosis of erythrocytes by the reticulohistiocytary system of isolated perfused rat liver. Arzneimittelforschung35(9), 1437–1439 (1985).
  • Wagner H. Leading structures of plant origin for drug development. J. Ethnopharmacol 38,105–112 (1993).
  • •Probably the first and a most comprehensive, review about immunostimulants derived from plant sources and their applications to patients.
  • Walker PS, Scharton-Kersten T, Krieg AM, et al. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-gamma-dependent mechanisms. Proc. Natl Acad. Sci. USA 96,6970–6975 (1999).
  • Wang GL, Lin ZB. The immunomodulatory effect of lentinan. Yao Xue Bao 31(2), 86–90 (1996).
  • Wang Y, Huang DS, Watson RR. in vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci 54(6), 401–411 (1994).
  • Wang ZT, Ng TB, Yeung HW, Xu GJ. Immunomodulatory effect of a polysaccharide-enriched preparation of Codonopsis pilosula roots. Genet. Phatmacol 27(8), 1347–1350 (1996).
  • Weighardt H, Feterowski C, Veit M, Rump M, Wagner H, Holzmann B. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol 165(8), 4537–4543 (2000).
  • •Describes conclusively how oligodeoxynucleotides containing CpG sequence motifs enhance immunological protection against infections.
  • Welch W, Foote M. The use of Filgrastim in AIDS-related neutropenia. Hematother. Stem. Cell Res. 8\(Suppl. 1), S9-16 (1999).
  • Williams NJ, Harvey JJ, Duncan I, Booth RF, Knight SC. Interleukin-12 restores dendritic cell function and cell-mediated immunity in retrovirus-infected mice. Cell Immunol 183,121–130 (1998).
  • Yap G, Pesin M, Sher A. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T-cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. I Immunol 165(2), 628–631 (2000).
  • Yasui H, Shida K, Matsuzaki T, Yokokura T Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 383–389 (1999).
  • Yu Q, Gu JX, Kovacs C, Freedman J, Thomas EK, Ostrowski MA. Co-operation of TNF family members CD40 ligand, receptor activator of NF-KB ligand and TNF-a in the activation of dendritic cells and the expansion of viral specific CD8+ T-cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. J. Immunol 170,1797–1805 (2003).
  • •An excellent paper on TNF-a and other members of the TNF-family also arguing their usage as beneficial imrnunomodulators.
  • Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacol 35(2), 119–128 (1996).
  • Zhang Y, Acuna CL, Switzer KC, Song L, Sayers R, Mbawuike IN. Corrective effects of interleukin-12 on age-related deficiencies in IFN-gamma production and IL-12Rbeta2 expression in virus-specific CD8+ T-cells. I Interfemn Cytokine Res. 20(2), 235–245 (2000).
  • Zhao HW, Li YH, Zhu YN, Wenig SA, Zhang Y, Ge SW Effect of brucine on mouse nonspecific immune responses. Zhongguo Yao Li Xue Bao. 18(5), 468–470 (1997).
  • Zimmermann S, Egeter O, Hausmann S, et al. CpG oligodeoxynucleotides trigger protective and curat1ive Thl responses in lethal murine leishmaniasis. I Immunol 160,3627–3630 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.